Lv33
360 积分 2024-05-09 加入
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
4小时前
已完结
In overweight or obesity without diabetes, weekly semaglutide vs. daily liraglutide increased weight loss at 68 wk
5小时前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
6小时前
已完结
The effect of GLP‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
4个月前
已完结
Chronic inflammation in obesity and neurodegenerative diseases: exploring the link in disease onset and progression
4个月前
已完结
Obesity-induced and weight-loss-induced physiological factors affecting weight regain
4个月前
已完结
The effect of GLP‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
4个月前
已完结
GLP-1-mediated targeting of inflammation corrects obesogenic memory in male mice
4个月前
已完结
Causes, consequences, and treatment of metabolically unhealthy fat distribution
4个月前
已完结
Multiomics insight into the role of glucagon‐like peptide‐1 receptor agonists in heart failure
4个月前
已完结
皖公网安备34019202002308
